02 Jun 2016 Targovax receives approval in Australia to conduct a clinical trial with TG02 - an immunotheraphy treatment targeting RAS mutations
25 May 2016 ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease
24 May 2016 Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four years of age and older
24 May 2016 Bavarian Nordic Announces Positive Top Line Results from a Phase 1 Trial of a Novel, Broad Spectrum RSV Vaccine in Healthy Adult and Elderly Populations
21 May 2016 Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine)
16 May 2016 This Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses in Non-Human Primates
14 May 2016 Pfizer Presents Results from Two Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Studies at the European Society for Paediatric Infectious Diseases Meeting
14 May 2016 NeOnc Technologies Announces Initiation of Phase 1/2a Clinical Trial of NEO100™ in Recurrent Glioblastoma Multiforme (GBM)
12 May 2016 OncBioMune Provides Update on Phase 2 Clinical Trials of ProscaVax for Prostate Cancer
11 May 2016 NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel-L for Patients with Resected Pancreatic Cancer
10 May 2016 Dr. Patrick Soon-Shiong Presents Promising Results of Novel Adenoviral Colon Cancer Vaccine in Treating End-Stage Colon Cancer at the Bank of America Merrill Lynch 2016 Health Care Conference
09 May 2016 Allergy Therapeutics announces positive top-line results from the PQBirch204 Phase II study for birch-induced seasonal allergic rhinitis
04 May 2016 SELLAS Life Sciences Announces Positive WT1 Cancer Vaccine (galinpepimut-S) Clinical Results at the 13th International Conference of the International Mesothelioma Interest Group (iMig)
04 May 2016 VAXIMM initiates Phase 2a study in advanced colorectal cancer with oral T-cell vaccine VXM01
02 May 2016 Pharos Biologicals Conducting Tests of a Novel Zika Vaccine
02 May 2016 SELLAS Life Sciences Group Announces Initiation of Galinpepimut-S (WT1 Cancer Vaccine) Phase 1 Clinical Trial in Combination with PD-1 Checkpoint Inhibitor for Patients with Ovarian Cancer
29 Apr 2016 CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders
26 Apr 2016 Journal of the American Medical Association Publishes Phase III Data from Allergic Asthma Trial with ALK's House Dust Mite SLIT-tablet, ACARIZAX
21 Apr 2016 TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute
19 Apr 2016 Global Public-Private Partnership Announces Publication of Positive Phase 1 Data for Ebola Vaccine Regimen in JAMA
19 Apr 2016 Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data at the American Association for Cancer Research (AACR) Annual Meeting
13 Apr 2016 PDS Biotechnology Reports Positive Phase 1 Study Results for PDS0101 Immunotherapy for HPV-Related Cancers
13 Apr 2016 Merck Announces FDA Acceptance of Biologics License Application for Investigational House Dust Mite Sublingual Allergy Immunotherapy Tablet
12 Apr 2016 DBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy
11 Apr 2016 Aimmune Therapeutics Presents Data on Biomarkers and Potential to Predict Response to Peanut Allergy Treatment With AR101

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing